Lol, that doesn't even make sense. A/S and O/S are two different animals. The 10 Billion share company you are referring to is the number of A/S, not the number of O/S. The company has documented what purposes the increase in A/S would be used for. The reasons are valid and common with start-up biotech companies. SVFC$$$$
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.